Key result
Dual antiplatelet therapy initiated within 24 hours modifies the early risk of recurrent stroke after a transient ischemic attack or minor stroke.
The editorial highlights the critical importance of urgent evaluation and early initiation of antiplatelet therapy to mitigate the high early risk of recurrent stroke following a TIA or minor stroke.
Although stroke is typically understood to be a medical emergency, the same pertains when cerebral ischemia produces seemingly mild or transient symptoms. For transient ischemic attack (TIA) and minor stroke, urgent evaluation and treatment are no less important than for larger strokes, given that the risk of recurrent stroke occurs early. Nearly half the 90-day stroke risk occurs within the first 48 hours after an event.1 The risk is modifiable with interventions such as aspirin2 or dual antiplatelet therapy with clopidogrel–aspirin3,4 or ticagrelor–aspirin5 if it is initiated within 24 hours. The trials that established the efficacy of short-term dual antiplatelet . . .
No takes yet. Share an insight, caveat, or question.
Anthony Kim (2023) conducted an editorial in Transient ischemic attack (TIA) or minor stroke. Dual antiplatelet therapy was evaluated. Dual antiplatelet therapy initiated within 24 hours modifies the early risk of recurrent stroke after a transient ischemic attack or minor stroke.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: